Paper FOR PenWu Device
After the customers used our products, the total impact factor of the papers they published reached over 400.
You can search in these papers: BJ-PW-M & BJ-PW-R & BJ-PW-FM-M & BJ-PW-FM-R & Bio Jane & PenWu Device for Mouse & PenWu Device for Rat and so on. These papers will show that.
Paper（Liquid）：
1. https://onlinelibrary.wiley.com/doi/abs/10.1002/adma.202007557
Nanoparticle-Mediated Delivery of Inhaled Immunotherapeutics for Treating Lung Metastasis
2. https://www.pnas.org/doi/full/10.1073/pnas.2102957118
Inhalable nanocatchers for SARS-CoV-2 inhibition
3. https://pubs.acs.org/doi/10.1021/jacs.1c08017
Renal-Clearable Molecular Probe for Near-Infrared Fluorescence Imaging and Urinalysis of SARS-CoV-2
4. https://www.nature.com/articles/s41401-021-00808-z
Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis
5. https://www.nature.com/articles/s41401-021-00618-3
Roxithromycin attenuates bleomycin-induced pulmonary fibrosis by targeting senescent cells
6. https://www.sciencedirect.com/science/article/pii/S1742706122003634
ROS-responsive polymer nanoparticles with enhanced loading of dexamethasone effectively modulate the lung injury microenvironment
7. https://doi.org/10.1007/s12274-021-4012-9
A chitosan-mediated inhalable nanovaccine against SARS-CoV-2
8. https://journals.physiology.org/doi/full/10.1152/ajplung.00560.2020
p55PIK deficiency and its NH2-terminal derivative inhibit inflammation and emphysema in COPD mouse model
9. https://doi.org/10.1002/btm2.10280
Macrophage-targeted delivery of siRNA to silence Mecp2 gene expression attenuates pulmonary fibrosis
10. https://doi.org/10.1183/13993003.03697-2020
The methyl-CpG-binding domain 2 facilitates pulmonary fibrosis by orchestrating fibroblast to myofibroblast differentiation
11. https://www.hindawi.com/journals/omcl/2022/9300269/ (2022)
MTMR14 Alleviates Chronic Obstructive Pulmonary Disease as a Regulator in Inflammation and Emphysema
12. https://www.sciencedirect.com/science/article/pii/S2666386422005641 (2023.1)
A cytoderm metabolic labeling AIEgen for rapid detection and intracellular ablation of Mycobacterium tuberculosis
13. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115697/ (2022.5)
Macrophage‐targeted delivery of siRNA to silence Mecp2 gene expression attenuates pulmonary fibrosis
14. https://pubs.acs.org/doi/full/10.1021/acsnano.3c00906 （2023.4）
A Multifunctional Nanoparticle Mitigating Cytokine Storm by Scavenging Multiple Inflammatory Mediators of Sepsis
15. https://onlinelibrary.wiley.com/doi/10.1002/smll.202300545 （2023.4）
Inhaled Lipid Nanoparticles Alleviate Established Pulmonary Fibrosis
16. https://www.sciengine.com/SCLS/doi/10.1007/s11427-022-2314-8;JSESSIONID=63cbf8c9-4345-4b3b-92ba-0efe5f8c34d4 （2023.4）
Local administration of liposomal-based Plekhf1 gene therapy attenuates pulmonary fibrosis by modulating macrophage polarization
17. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759842/
MTMR14 Alleviates Chronic Obstructive Pulmonary Disease as a Regulator in Inflammation and Emphysema
18. https://doi.org/10.1016/j.biomaterials.2023.122283
Inhalable pH-responsive DNA tetrahedron nanoplatform for boosting anti-tumor immune responses against metastatic lung cancer
19. https://doi.org/10.1021/acsnano.3c08660 （2023.12）
Inhalable Bottlebrush Polymer Bioconjugates as Vectors for Efficient Pulmonary Delivery of Oligonucleotides
20. https://doi.org/10.3390/pharmaceutics15071951 Pharmaceutics 2023, 15(7), 1951;
Systemic Protein Delivery via Inhalable Liposomes: Formulation and Pharmacokinetics
21．https://www.nature.com/articles/s41467-024-50312-1 (2024.7)
Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice
22. https://doi.org/10.1002/adfm.202408767 （2024.9）
Inhalation of Bioorthogonal Gene-Editable Spiky-Pollen Reprograms Tumor-Associated Macrophages for Lung Cancer Immunotherapy
23. https://onlinelibrary.wiley.com/doi/epdf/10.1002/adma.202311537（2024.1）
ACE2 Receptor-Targeted Inhaled Nanoemulsions Inhibit SARS-CoV-2 and Attenuate Inflammatory Responses
24. https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-024-05655-0 （2024.10）
Albendazole ameliorates aerobic glycolysis in myofibroblasts to reverse pulmonary fibrosis
25. https://pubs.acs.org/doi/10.1021/acsnano.4c15130 (2025.1)
Inhalable siRNA Targeting IL-11 Nanoparticles Significantly Inhibit Bleomycin-Induced Pulmonary Fibrosis
26. https://www.sciencedirect.com/science/article/pii/S1818087623000429 (2023.5)
Corrugated surface microparticles with chitosan and levofloxacin for improved aerodynamic performance
27. https://doi.org/10.1002/adma.202404264 (2024.6)
Chemically Programmed Hydrogels for Spatiotemporal Modulation of the Cardiac Pathological Microenvironment
28. https://doi.org/10.1007/s11426-024-2600-1 （2025.4）
Construct nucleic acid delivery carriers with excellent antibacterial capabilities for the treatment of bacterial MRSA-induced lung inflammation
29. https://www.sciencedirect.com/science/article/pii/S2090123224002546 （May 2025）
Kynurenine acts as a signaling molecule to attenuate pulmonary fibrosis by enhancing the AHR-PTEN axis
30. https://doi.org/10.1021/acsnano.5c05745 （June 9, 2025）
Harnessing Surface Hydrophilicity of Inhalable Nanoparticles for Precision Delivery of Glucagon-like Peptide‑1 Receptor Agonists or Anti-Asthmatic Therapeutics
31. https://www.nature.com/articles/s41467-023-40185-1
Trimannose-coupled antimiR-21 for macrophage-targeted inhalation treatment of acute inflammatory lung damage
Dry powder：
1. https://doi.org/10.1016/j.powtec.2022.117679
Co-achievement of enhanced absorption and elongated retention of insoluble drug in lungs for inhalation therapy of pulmonary fibrosis
2. https://www.sciencedirect.com/science/article/pii/S0168365923002791 (2023.6)
Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation
3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786194/（2022.12）
Development and Pharmacokinetics of a Novel Acetylsalicylic Acid Dry Powder for Pulmonary Administration
4. https://www.sciencedirect.com/science/article/pii/S1818087623000429 (2023.5)
Corrugated surface microparticles with chitosan and levofloxacin for improved aer
已发表的Paper 总影响因子400+